Resistance of cancer cells to oncotherapeutics designed to trigger programmed cell death (a.k.a. apoptosis) greatly limits clinical efficacy. The human FLN29 protein may play a role in this process via protein-protein interactions. Here we report the NMR spectral assignment of the N-terminal TRAF2/6-RING-zinc finger-like domain of this protein.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12104-007-9077-1 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!